Author | Richard Finn, MD | OncLive

Author | Richard Finn, MD

Articles

Dr. Finn on Considerations for Lenvatinib in Liver Cancer

September 19, 2018

Video

Richard Finn, MD, associate professor of medicine, University of California, Los Angeles David Geffen School of Medicine, discusses the role of lenvatinib in the treatment of patients with liver cancer.

Dr. Finn on Role of Lenvatinib in HCC Treatment Paradigm

September 16, 2018

Video

Richard Finn, MD, professor of clinical medicine in the Division of Hematology and Oncology, director of the Signal Transduction and Therapeutics Program at the Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at the University of California, Los Angeles, discusses the role lenvatinib (Lenvima) in the treatment paradigm for advanced hepatocellular carcinoma.

Dr. Finn on Significance of Phase III Findings of Lenvatinib in HCC

September 16, 2017

Video

Richard Finn, MD, associate professor of medicine at the UCLA David Geffen School of Medicine, discusses the significance of the phase III trial of frontline lenvatinib (Lenvima) versus sorafenib (Nexavar) in patients with hepatocellular carcinoma (HCC).

Dr. Finn on Current and Emerging Agents in the Field of HCC

September 16, 2017

Video

Richard Finn, MD, associate professor of medicine at the UCLA David Geffen School of Medicine, shares insight on some current and emerging agents in the field of hepatocellular carcinoma (HCC).

x